TrevorAngellMD
Endocrinology • Los Angeles, CADiabetes, Lipid Metabolism, Thyroid
Assistant Professor Associated Medical Director of Thyroid Keck School of Medicine University of Southern California Los Angeles, CA
Dr. Angell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 San Pablo St
Ste 1000
Los Angeles, CA 90033Phone+1 323-442-5100Fax+1 323-442-5953
Education & Training
Los Angeles General Medical CenterFellowship, Research Endocrinology, 2013 - 2014- University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2013
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2010 - 2012
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 2009 - 2010
Keck School of Medicine of the University of Southern CaliforniaClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2026
MA State Medical License 2014 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 17 citationsMolecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear ...Kyle C. Strickland, Markus Eszlinger, Ralf Paschke, Trevor E. Angell, Erik K. Alexander
Endocrine Pathology. 2018-03-01 - 12 citationsPreoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier.Gregory W Randolph, Julie Ann Sosa, Yangyang Hao, Trevor E Angell, David C Shonka , Jr
Thyroid. 2022-09-01 - 105 citationsMHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In VitroTrevor E. Angell, Melissa G. Lechner, Julie K. Jang, Jonathan S. LoPresti, Alan L. Epstein
Clinical Cancer Research. 2014-12-01
Journal Articles
- Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Exten...Matthew A Nehs, Erik K Alexander, Nancy L Cho, Brenessa M Lindeman, Atul A Gawande, Trevor E Angell, Annals of Surgical Oncology
- Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid NodulesMichael H Shanik, Paul W Ladenson, Peter M Sadow, Julie A Sosa, Ronald A Ghossein, S Thomas Traweek, Neil M Barth, Kepal N Patel, Trevor E Angell, Richard T Kloos, Vir..., JAMA
Authored Content
- The T3 Debate Rages on at ENDO2024June 2024
- At ENDO 2021, Experts Guide on Thyroid CareMarch 2021
- At ATA, 'Thy-Mazing' TreatmentsNovember 2019
Press Mentions
Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024- Study Suggests Inappropriate Use of Thyroid UltrasoundsDecember 19th, 2023
- The Beginning of the American Thyroid Association Centennial YearJanuary 1st, 2023
- Join now to see all
Committees
- Past Chair, American Thyroid Association Patient Affairs and Education Committee 2020 - Present
- Chair, American Thyroid Association Patient Affairs and Education Committee 2018 - 2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
